PubRank

A D Osterhaus

Author PubWeight™ 402.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001 16.32
2 Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998 16.30
3 Emerging marine diseases--climate links and anthropogenic factors. Science 1999 10.22
4 A pandemic warning? Nature 1997 8.70
5 Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 2012 7.96
6 Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995 7.26
7 Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene. J Clin Microbiol 2000 6.96
8 Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997 6.23
9 Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000 5.03
10 Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill 2012 4.95
11 Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001 4.90
12 Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 1998 3.67
13 Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill 2013 2.97
14 Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol 1997 2.86
15 Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 2000 2.25
16 Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin Diagn Lab Immunol 2000 2.21
17 Human influenza virus A/HongKong/156/97 (H5N1) infection. Vaccine 1998 2.17
18 Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 2000 2.11
19 Haemorrhagic fever with renal syndrome. Lancet 1993 2.09
20 Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS. J Gen Virol 1997 2.07
21 Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000 2.07
22 Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 2001 2.06
23 Canine distemper virus from diseased large felids: biological properties and phylogenetic relationships. J Gen Virol 1996 2.06
24 An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Acta Virol 1999 2.06
25 Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies. Arch Intern Med 1999 2.01
26 Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000 1.95
27 Influenza types and patient population. Lancet 1995 1.94
28 Measles in a Dutch hospital introduced by an immuno-compromised infant from Indonesia infected with a new virus genotype. Lancet 2000 1.87
29 Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2007 1.83
30 Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol 2001 1.70
31 Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob Agents Chemother 2000 1.66
32 Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 1994 1.65
33 Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. Arch Virol 2000 1.61
34 Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J Gen Virol 1997 1.61
35 Identification of virus causing recent seal deaths. Nature 1988 1.58
36 Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults. Vaccine 1996 1.55
37 Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. Int J Epidemiol 2001 1.53
38 Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. Blood 2001 1.52
39 PCBs are a health risk for humans and wildlife. Science 2000 1.51
40 Influenza virus: a master of metamorphosis. J Infect 2000 1.50
41 Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. J Virol 1993 1.50
42 The hanta hunting study: underdiagnosis of Puumala hantavirus infections in symptomatic non-travelling leptospirosis-suspected patients in the Netherlands, in 2010 and April to November 2011. Euro Surveill 2014 1.49
43 Canine distemper virus--a morbillivirus in search of new hosts? Trends Microbiol 1997 1.49
44 Recommendations for the use of inactivated influenza vaccines and other preventive measures. Vaccine 2001 1.47
45 Mass die-Off of Caspian seals caused by canine distemper virus. Emerg Infect Dis 2001 1.46
46 [Influenza pandemics: past and future]. Ned Tijdschr Geneeskd 1999 1.42
47 Herpes simplex virus type 1 (HSV-1)--induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol 2000 1.42
48 Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment. J Infect Dis 1998 1.42
49 Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. J Virol 2000 1.39
50 Kinetics of antiviral activity by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) and rapid selection of CTL escape virus in vitro. J Virol 1998 1.39
51 Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 2001 1.38
52 Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scand J Immunol 1995 1.38
53 Monoclonal antibodies to polioviruses. Comparison of intratypic strain differentiation of poliovirus type 1 using monoclonal antibodies versus cross-absorbed antisera. Intervirology 1983 1.35
54 Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol 1990 1.35
55 Characterization of fastidious adenovirus types 40 and 41 by DNA restriction enzyme analysis and by neutralizing monoclonal antibodies. Virus Res 1989 1.34
56 An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch Virol 1990 1.34
57 Combination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measles. J Clin Microbiol 2001 1.34
58 Detection, typing, and subtyping of enteric adenoviruses 40 and 41 from fecal samples and observation of changing incidences of infections with these types and subtypes. J Clin Microbiol 1993 1.31
59 Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands. Virology 2001 1.30
60 Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol 1989 1.29
61 Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 1997 1.29
62 New clues to the emergence of flu pandemics. Nat Med 1998 1.28
63 ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus. Vaccine 1999 1.28
64 Development of a real-time quantitative RT-PCR for the detection of HIV-2 RNA in plasma. J Virol Methods 2000 1.28
65 The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL. J Immunol 1990 1.28
66 Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J Exp Med 1992 1.27
67 Antigen loading of MHC class I molecules in the endocytic tract. Traffic 2001 1.27
68 A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines. Vaccine 2000 1.26
69 Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma. Blood 2001 1.25
70 Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol 1997 1.24
71 Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy. AIDS 1998 1.24
72 Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains. Intervirology 1981 1.23
73 Canine distemper virus in seals. Nature 1988 1.22
74 Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody. J Immunol 1985 1.21
75 Characterization of phocid herpesvirus-1 and -2 as putative alpha- and gammaherpesviruses of North American and European pinnipeds. J Gen Virol 1996 1.20
76 Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies. AIDS 1993 1.19
77 Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res Hum Retroviruses 1990 1.19
78 Herpes simplex virus 1 transmission through corneal transplantation. Lancet 2001 1.18
79 First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J Virol 1994 1.17
80 A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J Virol 1993 1.16
81 The athymic nude rat. III. Natural cell-mediated cytotoxicity. Clin Immunol Immunopathol 1980 1.15
82 Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J Virol 1992 1.15
83 Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol 1989 1.15
84 Contaminant-related suppression of delayed-type hypersensitivity and antibody responses in harbor seals fed herring from the Baltic Sea. Environ Health Perspect 1995 1.14
85 Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. J Virol 1995 1.14
86 Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum. J Clin Microbiol 2000 1.13
87 An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg 1999 1.11
88 Antiviral resistance of biologic HIV-2 clones obtained from individuals on nucleoside reverse transcriptase inhibitor therapy. J Acquir Immune Defic Syndr 2000 1.09
89 Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine 1999 1.08
90 Relative immunocompetence of the newborn harbour seal, Phoca vitulina. Vet Immunol Immunopathol 1994 1.07
91 Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay. J Virol Methods 1998 1.07
92 Human peripheral blood lymphocytes from recently vaccinated individuals produce both type-specific and intertypic cross-reacting neutralizing antibody on in vitro stimulation with one type of poliovirus. J Immunol 1985 1.07
93 The virology and pathogenesis of feline infectious peritonitis. Brief review. Arch Virol 1979 1.07
94 Characterisation of a recently isolated lyssavirus in frugivorous zoo bats. Arch Virol 2000 1.06
95 Type 1-like immune response is found in children with respiratory syncytial virus infection regardless of clinical severity. J Med Virol 2000 1.06
96 Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum. J Clin Microbiol 1998 1.06
97 Contaminant-induced immunosuppression and mass mortalities among harbor seals. Toxicol Lett 2000 1.06
98 Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. J Infect Dis 2001 1.06
99 Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine 1995 1.05
100 The plea against annual influenza vaccination? 'The Hoskins' Paradox' revisited. Vaccine 1998 1.05
101 Temperature-sensitive mutants of mouse hepatitis virus strain A59: isolation, characterization and neuropathogenic properties. Virology 1983 1.05
102 Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice. J Gen Virol 1988 1.04
103 Inhibition of influenza virus replication by nitric oxide. J Virol 1999 1.04
104 Local variability in respiratory syncytial virus disease severity. Arch Dis Child 1997 1.04
105 Antigenic drift in swine influenza H3 haemagglutinins with implications for vaccination policy. Vaccine 1999 1.03
106 A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism. Vet Immunol Immunopathol 1995 1.03
107 Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals. Discrepancy between T cell-dependent and T cell-independent activation. J Immunol 1987 1.02
108 Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature. Clin Drug Investig 1998 1.02
109 Coreceptor usage of human immunodeficiency virus type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities. J Virol 1998 1.02
110 Monkeys in measles research. Curr Top Microbiol Immunol 1995 1.02
111 Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study. AIDS 1992 1.01
112 IgM antibodies in hospitalized children with febrile illness during an inter-epidemic period of measles, in Somalia. J Clin Virol 1999 1.01
113 Amplification of reiterated sequences of herpes simplex virus type 1 (HSV-1) genome to discriminate between clinical HSV-1 isolates. J Clin Microbiol 1999 1.00
114 Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 2012 0.99
115 A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards. J Clin Microbiol 2000 0.99
116 Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol 1993 0.99
117 Hantavirus infections in The Netherlands: epidemiology and disease. Epidemiol Infect 1995 0.99
118 A macaque model for hantavirus infection. J Infect Dis 1995 0.99
119 Antigenic heterogeneity within influenza A (H3N2) virus strains. Bull World Health Organ 1988 0.99
120 A synthetic peptide derived from the amino acid sequence of canine parvovirus structural proteins which defines a B cell epitope and elicits antiviral antibody in BALB c mice. J Gen Virol 1990 0.99
121 Production and potential use of monoclonal antibodies against polio viruses. Dev Biol Stand 1981 0.98
122 Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host. Acta Virol 2000 0.98
123 Towards an HIV-1 vaccine: lessons from studies in macaque models. Vaccine 1998 0.97
124 HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol 2000 0.97
125 Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons. J Infect Dis 1996 0.97
126 Influenza virus serology--a comparative study. J Virol Methods 1999 0.97
127 Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000 0.96
128 Diagnostic value of dengue virus-specific IgA and IgM serum antibody detection. Microbes Infect 1999 0.96
129 An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation 2000 0.95
130 Feline infectious peritonitis: a worldwide serosurvey. Am J Vet Res 1979 0.95
131 Dolphin morbillivirus infection in different parts of the Mediterranean Sea. Arch Virol 1993 0.95
132 An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum. Dev Biol Stand 1990 0.95
133 Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium. Vaccine 1999 0.95
134 Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells. Invest Ophthalmol Vis Sci 2000 0.94
135 Identification and characterization of herpes simplex virus-specific CD4+ T cells in corneas of herpetic stromal keratitis patients. J Infect Dis 1998 0.94
136 Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein. J Virol 1995 0.94
137 Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I. AIDS Res Hum Retroviruses 1990 0.94
138 Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. AIDS 1993 0.93
139 Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells. Clin Exp Immunol 2001 0.93
140 Morbillivirus infection in Mediterranean striped dolphins (Stenella coeruleoalba). Vet Rec 1991 0.93
141 Low number of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24-specific serum antibody titers. AIDS 1991 0.93
142 Identification of Hantavirus serotypes by testing of post-infection sera in immunofluorescence and enzyme-linked immunosorbent assays. J Med Virol 1991 0.93
143 Phylogenetic evidence of canine distemper virus in Serengeti's lions. Vaccine 1995 0.93
144 Impaired cellular immune response in harbour seals (Phoca vitulina) feeding on environmentally contaminated herring. Clin Exp Immunol 1995 0.93
145 Impairment of in vitro immune responses occurs within 3 months after HIV-1 seroconversion. AIDS 1990 0.92
146 Seroepidemiology of feline infectious peritonitis virus infections using transmissible gastroenteritis virus as antigen. Zentralbl Veterinarmed B 1977 0.92
147 Characterisation of morbilliviruses isolated from Lake Baikal seals (Phoca sibirica). Vet Microbiol 1995 0.92
148 Mitogen and antigen induced B and T cell responses of peripheral blood mononuclear cells from the harbour seal (Phoca vitulina). Vet Immunol Immunopathol 1993 0.92
149 Impaired immunity in harbour seals (Phoca vitulina) exposed to bioaccumulated environmental contaminants: review of a long-term feeding study. Environ Health Perspect 1996 0.92
150 Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome. Neurology 2000 0.91
151 Identification and characterization of a papillomavirus from birds (Fringillidae). Intervirology 1977 0.91
152 CD4 T cells remain the major source of HIV-1 during end stage disease. AIDS 1999 0.91
153 Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy. Vaccine 2001 0.91
154 Morbillivirus infections in aquatic mammals. Vet Res 1993 0.91
155 Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities. AIDS Res Hum Retroviruses 1992 0.90
156 Epitopes on the peplomer protein of infectious bronchitis virus strain M41 as defined by monoclonal antibodies. Virology 1987 0.90
157 Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2. N Engl J Med 2000 0.90
158 Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera. J Virol Methods 2000 0.90
159 [The 2002/2003 influenza season in the Netherlands and the vaccine composition for the 2003/2004 season]. Ned Tijdschr Geneeskd 2003 0.90
160 Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes. J Gen Virol 1994 0.90
161 Canine distemper virus in Lake Baikal seals (Phoca sibirica). Vet Rec 1996 0.90
162 Low prevalence of antibodies against the zoonotic agents Brucella abortus, Leptospira spp., Streptococcus suis serotype II, hantavirus, and lymphocytic choriomeningitis virus among veterinarians and pig farmers in the southern part of The Netherlands. Vet Q 1999 0.89
163 Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections. J Pediatr 2000 0.89
164 Seal vaccination success. Nature 1989 0.89
165 Morbilliviruses in aquatic mammals: report on round table discussion. Vet Microbiol 1995 0.89
166 Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine. Vaccine 1999 0.89
167 Herpes simplex virus type 1 (HSV-1)--induced retinitis following herpes simplex encephalitis: indications for brain-to-eye transmission of HSV-1. Ann Neurol 2001 0.89
168 Fusion protein gene nucleotide sequence similarities, shared antigenic sites and phylogenetic analysis suggest that phocid distemper virus type 2 and canine distemper virus belong to the same virus entity. J Gen Virol 1993 0.89
169 Morbilliviruses in Mediterranean monk seals. Vet Microbiol 1999 0.89
170 Epizootic of morbilliviral disease in common dolphins (Delphinus delphis ponticus) from the Black sea. Vet Rec 1999 0.88
171 Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure. J Virol 2001 0.88
172 Hantavirus antigen detection in kidney biopsies from patients with nephropathia epidemica. Clin Nephrol 1996 0.88
173 Different hantavirus serotypes in western Europe. Lancet 1991 0.88
174 Use of cotton rats for preclinical evaluation of measles vaccines. Vaccine 2000 0.88
175 Persistent infection of some standard cell lines by lymphocytic choriomeningitis virus: transmission of infection by an intracellular agent. J Virol 1983 0.88
176 Structure and amount of genetic variation at minisatellite loci within the subspecies complex of Phoca vitulina (the harbour seal). Heredity (Edinb) 1997 0.88
177 Morbilliviruses and morbillivirus diseases of marine mammals. Infect Agents Dis 1995 0.88
178 Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B. J Med Virol 1997 0.87
179 Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia. Epidemiol Infect 2000 0.87
180 Delineation of canine parvovirus T cell epitopes with peripheral blood mononuclear cells and T cell clones from immunized dogs. J Gen Virol 1990 0.87
181 Genetic analysis of Asian measles virus strains--new endemic genotype in Nepal. Virus Res 2001 0.87
182 Canine distemper virus ISCOMs induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1. Vaccine 1992 0.86
183 T cells specific for the triggering virus infiltrate the eye in patients with herpes simplex virus-mediated acute retinal necrosis. J Infect Dis 1998 0.86
184 A human CD5+ B cell clone that secretes an idiotype-specific high affinity IgM monoclonal antibody. J Immunol 1991 0.86
185 A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine 2001 0.86
186 Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection. J Gen Virol 1988 0.86
187 G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol 2000 0.86
188 The use of enzyme-linked immunosorbent assay systems for serology and antigen detection in parvovirus, coronavirus and rotavirus infections in dogs in The Netherlands. Vet Microbiol 1991 0.86
189 Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV). J Immunol 1983 0.85
190 In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components. Vaccine 2000 0.85
191 Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. J Gen Virol 1996 0.85
192 From Jenner to Jerne: towards idiotype vaccines. Immunol Rev 1986 0.85
193 Identification of morbilliviruses of probable cetacean origin in carcases of Mediterranean monk seals (Monachus monachus). Vet Rec 2000 0.85
194 Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies. J Gen Virol 1997 0.85
195 Cytotoxic T lymphocyte responses against measles virus. Curr Top Microbiol Immunol 1994 0.85
196 Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection. J Gen Virol 1999 0.85
197 Serum antibodies to structural proteins of Hantavirus arise at different times after infection. J Med Virol 1992 0.85
198 Isolation of a virus closely related to feline panleukopenia virus from dogs with diarrhea. Zentralbl Veterinarmed B 1980 0.84
199 Use of recombinant nucleoproteins in enzyme-linked immunosorbent assays for detection of virus-specific immunoglobulin A (IgA) and IgG antibodies in influenza virus A- or B-infected patients. J Clin Microbiol 1998 0.84
200 HIV-2 infection in 12 European residents: virus characteristics and disease progression. AIDS 1996 0.84
201 Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture. J Clin Microbiol 1995 0.84
202 Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine. J Gen Virol 1994 0.84
203 Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development. Vaccine 2001 0.84
204 Intraocular T cells of patients with herpes simplex virus (HSV)-induced acute retinal necrosis recognize HSV tegument proteins VP11/12 and VP13/14. J Infect Dis 2000 0.84
205 Isolation and characterization of a papovavirus from cynomolgus macaque kidney cells. Virology 1984 0.84
206 Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5). J Virol 1995 0.84
207 Acute renal failure due to leptospirosis grippotyphosa. Infection 1998 0.83
208 Impact of natural sequence variation in the V2 region of the envelope protein of human immunodeficiency virus type 1 on syncytium induction: a mutational analysis. J Gen Virol 1995 0.83
209 Selective inhibitory effects of (S)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (phocid herpesvirus 1) infection in vitro. Antiviral Res 1987 0.83
210 Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains. J Gen Virol 1995 0.83
211 Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg. Vaccine 2001 0.83
212 Antibodies to phocine distemper virus in Canadian seals. Vet Rec 1992 0.83
213 [2000/01 influenza season and the vaccine composition for the season 2001/'02]. Ned Tijdschr Geneeskd 2001 0.83
214 Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines. J Med Primatol 1992 0.83
215 Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen, II. Cellular, but not humoral, systemic immune responses against rabies virus immune-stimulating complexes are macrophage dependent. Immunology 1998 0.83
216 Monoclonal antibodies to the three classes of mouse hepatitis virus strain A59 proteins. Adv Exp Med Biol 1984 0.82
217 Canine viral enteritis: prevalence of parvo-, corona- and rotavirus infections in dogs in the Netherlands. Tijdschr Diergeneeskd 1980 0.82
218 Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies. Vet Immunol Immunopathol 1995 0.82
219 Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy. J Viral Hepat 2000 0.82
220 Studies on the efficacy of hyperbaric rendering procedures in inactivating bovine spongiform encephalopathy (BSE) and scrapie agents. Vet Rec 1998 0.82
221 Establishment and characterization of canine parvovirus-specific murine CD4+ T cell clones and their use for the delineation of T cell epitopes. J Gen Virol 1990 0.82
222 Prevention of measles in Sudan: a prospective study on vaccination, diagnosis and epidemiology. Vaccine 2001 0.82
223 Morbillivirus infection in a bottlenosed dolphin and a Mediterranean monk seal from the Atlantic coast of West Africa. Vet Rec 2001 0.82
224 Fatal cerebral oedema associated with primary dengue infection. J Infect 1998 0.82
225 Elimination of Mycoplasma from cell cultures by means of specific bovine antiserum. Zentralbl Bakteriol Mikrobiol Hyg A 1987 0.82
226 Occupational risks of zoonotic infections in Dutch forestry workers and muskrat catchers. Eur J Epidemiol 1998 0.81
227 Guillain-Barré syndrome associated with hantavirus infection. Lancet 1994 0.81
228 Antigen detection in vivo after immunization with different presentation forms of rabies virus antigen: involvement of marginal metallophilic macrophages in the uptake of immune-stimulating complexes. Eur J Immunol 1995 0.81
229 A rat cytomegalovirus infection model as a tool for immunotoxicity testing. Eur J Pharmacol 1995 0.81
230 Construction and evaluation of an expression vector allowing the stable expression of foreign antigens in a Salmonella typhimurium vaccine strain. Vaccine 1994 0.81
231 Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 2001 0.81
232 Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex. J Gen Virol 2000 0.81
233 Inactivated poliovirus vaccine: current production methods and new developments. Rev Infect Dis 1984 0.81
234 [Influenza A (H5N1) in Hong Kong: Forerunner of a pandemic or just a scientifically interesting phenomenon and a useful exercise in pandemiology?]. Ned Tijdschr Geneeskd 1998 0.80
235 Characteristics of the early phase of chronicity in acute hepatitis B infection. J Med Virol 1999 0.80
236 Feline infectious peritonitis: a coronavirus disease of cats. J Small Anim Pract 1978 0.80
237 Methods for the purification of equine rabies immunoglobulin: effects on yield and biological activity. Biologicals 1994 0.80
238 Detection of IgA antibodies and quantification of IgA antibody-producing cells specific for ovalbumin or Trichinella spiralis in the rat. Scand J Immunol 1988 0.80
239 MVA: a cuckoo in the vaccine nest? Vaccine 2001 0.80
240 A comparison of an enzyme-linked immunosorbent assay and counter current electrophoresis for the detection of bovine serum albumin in virus vaccines. J Biol Stand 1987 0.80
241 An outbreak of a herpesvirus infection in harbor seals (Phoca vitulina). J Wildl Dis 1986 0.80
242 High influenza morbidity and mortality in unvaccinated elderly people in Curaçao. J Infect 1998 0.80
243 Evaluation of a fully automated glycoprotein G-2 based assay for the detection of HSV-2 specific IgG antibodies in serum and plasma. J Clin Virol 1999 0.80
244 CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26. J Gen Virol 1997 0.79
245 [Hantaan virus infection in Twente]. Ned Tijdschr Geneeskd 1991 0.79
246 Hantavirus nephropathy in The Netherlands: clinical, histopathological and epidemiological findings. Neth J Med 1995 0.79
247 Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections. Vet Q 1990 0.79
248 Suppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production. Liver 2001 0.79
249 Major immunogenic proteins of phocid herpes-viruses and their relationships to proteins of canine and feline herpesviruses. Vet Q 1998 0.79
250 Continued presence of phocine distemper virus in the Dutch Wadden Sea seal population. Vet Rec 1993 0.79
251 gag- and env-specific serum antibodies in cats after natural and experimental infection with feline immunodeficiency virus. Vet Microbiol 1994 0.79
252 Monoclonal antibodies to Treponema pallidum. Dev Biol Stand 1984 0.79
253 Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection. Scand J Immunol 1994 0.79
254 Coronavirus-like particles in laboratory rabbits with different syndromes in the Netherlands. Lab Anim Sci 1982 0.79
255 Rinderpest virus (RPV) ISCOM vaccine induces protection in cattle against virulent RPV challenge. Vaccine 2001 0.79
256 Monoclonal antibodies against herpes simplex viruses. Dev Biol Stand 1984 0.79
257 Hantavirus nephropathy in Netherlands. Lancet 1989 0.79
258 Mousepox in the Netherlands. Lab Anim Sci 1981 0.79
259 Impaired cellular immune response in rats exposed perinatally to Baltic Sea herring oil or 2,3,7,8-TCDD. Arch Toxicol 1997 0.79
260 Measles virus-specific murine T cell clones: characterization of fine specificity and function. J Immunol 1989 0.79
261 Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems. Vaccine 1997 0.79
262 Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activation of specific CD8(+) cytotoxic T lymphocytes. Vaccine 2000 0.79
263 Presence of non-maternal antibodies in newborns of mothers with antibody deficiencies. Pediatr Res 1992 0.78
264 Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samples. J Clin Virol 2000 0.78
265 Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories. Vaccine 1995 0.78
266 Host resistance to rat cytomegalovirus (RCMV) and immune function in adult PVG rats fed herring from the contaminated Baltic Sea. Arch Toxicol 1996 0.78
267 Identification of bovine leukemia virus (BLV) infected cattle by complex-trapping-blocking (CTB) ELISA employing monoclonal antibodies directed against BLV-p24. Zentralbl Veterinarmed B 1987 0.78
268 [Hantavirus infections in the Netherlands]. Ned Tijdschr Geneeskd 1984 0.78
269 Comparative immunological characterization of type-specific and conserved B-cell epitopes of pinniped, felid and canid herpesviruses. Arch Virol 1994 0.78
270 [Influenza season 1998/99; composition of vaccine for 1999/2000]. Ned Tijdschr Geneeskd 1999 0.78
271 Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells. Vet Immunol Immunopathol 1998 0.78
272 Post-exposure treatment with monoclonal antibodies in a retrovirus system: failure to protect cats against feline leukemia virus infection with virus neutralizing monoclonal antibodies. Int J Cancer 1986 0.78
273 Cytotoxic T lymphocytes in AIDS pathogenesis: lessons to be learned from the macaque model of simian immunodeficiency virus infection. J Gen Virol 1998 0.78
274 [Influenza in the 1993/'94 season; composition of the vaccine for the 1994/'95 season]. Ned Tijdschr Geneeskd 1994 0.78
275 Serologic survey for phocid herpesvirus-1 and -2 in marine mammals from Alaska and Russia. J Wildl Dis 1997 0.78
276 Human antibodies that neutralize primary human immunodeficiency virus type 1 in vitro do not provide protection in an in vivo model. J Gen Virol 1996 0.78
277 Immunoregulation mother-fetus/newborn, a role for anti-idiotypic antibodies. Acta Paediatr Scand Suppl 1989 0.78
278 [Influenza in the 1995/'96 season; vaccine composition for the 1996/'97 season]. Ned Tijdschr Geneeskd 1996 0.78
279 Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. Vaccine 1993 0.78
280 Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein. J Gen Virol 1989 0.78
281 Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model. J Gen Virol 2000 0.78
282 Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. J Gen Virol 1993 0.78
283 [Influenza season 1999/2000 and vaccine composition for the season 2000/01]. Ned Tijdschr Geneeskd 2000 0.78
284 Impaired immunity in harbour seals [Phoca vitulina] fed environmentally contaminated herring. Vet Q 1996 0.77
285 In vitro processing and presentation of a lipidated cytotoxic T-cell epitope derived from measles virus fusion protein. Vaccine 2001 0.77
286 Inhibition of measles virus-induced cell-cell fusion with a monoclonal antibody directed against the haemagglutinin. Viral Immunol 1987 0.77
287 Monoclonal anti-idiotypic antibody vaccines against poliovirus, canine parvovirus, and rabies virus. Methods Enzymol 1989 0.77
288 Analysis of antigenic relationships among influenza virus strains using a taxonomic cluster procedure. Comparison of three kinds of antibody preparations. J Virol Methods 1985 0.77
289 Risk of infections transmitted by arthropods and rodents in forestry workers. Eur J Epidemiol 1994 0.77
290 The isolation and partial characterization of a highly pathogenic herpesvirus from the harbor seal (Phoca vitulina). Arch Virol 1985 0.77
291 Monoclonal antibodies for the control of influenza virusvaccines. Dev Biol Stand 1984 0.77
292 Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection. Vaccine 1998 0.77
293 Serological investigation of virus infections in harp seals (Phoca groenlandica) and hooded seals (Cystophora cristata). Vet Rec 1994 0.77
294 Feline infectious peritonitis (FIP) virus. III. Studies on the multiplication of FIP virus in the suckling mouse. Zentralbl Veterinarmed B 1978 0.77
295 Control of feline leukaemia virus. Vet Immunol Immunopathol 1989 0.76
296 Chimpanzees in AIDS research: a biomedical and bioethical perspective. J Med Primatol 1994 0.76
297 Prevalence of antibodies to equine viruses in the Netherlands. Tijdschr Diergeneeskd 1979 0.76
298 An unusual cause of a usual presentation. Hantavirus infection. Neth J Med 2011 0.76
299 Decline of simian immunodeficiency virus (SIV)-specific cytotoxic T lymphocytes in the peripheral blood of long-term nonprogressing macaques infected with SIVmac32H-J5. J Infect Dis 1999 0.76
300 Scrub and murine typhus among Dutch travellers. Infection 1999 0.76
301 Anti-idiotypic antibodies to poliovirus antibodies in commercial immunoglobulin preparations, human serum, and milk. Pediatr Res 1993 0.76
302 Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. AIDS Res Hum Retroviruses 1994 0.76
303 Class and subclass distribution of Hantavirus-specific serum antibodies at different times after the onset of nephropathia epidemica. J Med Virol 1994 0.76
304 Chimpanzees in AIDS research: a biomedical and bioethical perspective. J Med Primatol 1994 0.76
305 Induction and characterization of monoclonal anti-idiotypic antibodies reactive with idiotopes of canine parvovirus neutralizing monoclonal antibodies. Vet Immunol Immunopathol 1991 0.76
306 An inhibition enzyme immunoassay using a human monoclonal antibody (K14) reactive with gp41 of HIV-1 for the serology of HIV-1 infections. AIDS 1991 0.75
307 Molecular characterization and baculovirus expression of the glycoprotein B of a seal herpesvirus (phocid herpesvirus-1). Virology 1997 0.75
308 First sporadic case of Hantavirus nephropathy, recognised in The Netherlands. Neth J Med 1989 0.75
309 [Avian influenza and oseltamivir; a retrospective view]. Ned Tijdschr Geneeskd 2003 0.75
310 Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells. Dev Biol Stand 1999 0.75
311 Influenza types and patient population. Lancet 1996 0.75
312 The evaluation of a physical method for the quantification of inactivated poliovirus particles and its relationship to D-antigenicity and potency testing in rats. J Biol Stand 1984 0.75
313 A case of human rabies in The Netherlands. Infection 1998 0.75
314 Salmonella typhimurium aroA recombinants and immune-stimulating complexes as vaccine candidates for feline immunodeficiency virus. J Gen Virol 1997 0.75
315 Feline infectious peritonitis (FIP) virus. IV. Propagation in suckling rat and hamster brain. Zentralbl Veterinarmed B 1978 0.75
316 Detection by immunofluorescence of transmissible gastroenteritis (TGE) viral antigen in pigs, using cat anti feline infectious peritonitis (FIP) virus conjugate. Zentralbl Veterinarmed B 1978 0.75
317 [The influenza season 1997/'98 and the vaccine composition for 1998/'99]. Ned Tijdschr Geneeskd 1998 0.75
318 [Influenza A(H5N1) in Hong Kong: forerunner of a pandemic or an only scientifically interesting phenomenon and a useful exercise in pandemiology?]. Tijdschr Diergeneeskd 1998 0.75
319 [Vaccination against kennel-cough?]. Tijdschr Diergeneeskd 1977 0.75
320 Vaccines from monoclonal anti-idiotypic antibody: poliovirus infection as a model. Curr Top Microbiol Immunol 1985 0.75
321 Molecular and serological studies on the recent seal virus epizootics in Europe and Siberia. Sci Total Environ 1992 0.75
322 Purification process monitoring in monoclonal antibody preparation: contamination with viruses, DNA and peptide growth factors. Biologicals 1992 0.75
323 [CD4+-T-cells are the predominant source of HIV-1 and HIV-2 production in asymptomatic people and AIDS patients with opportunistic infections]. Ned Tijdschr Geneeskd 1998 0.75
324 An enzyme-linked immunosorbent assay for the detection of mouse polyomavirus-specific antibodies in laboratory mice. Lab Anim 1994 0.75
325 Application of monoclonal antibodies in the avian leukosis virus GS-antigen ELISA. Avian Pathol 1985 0.75
326 Development of a vaccine against AIDS: state of the art. Neth J Med 1991 0.75
327 [Bovine spongiform encephalitis (BSE)]. Tijdschr Diergeneeskd 1996 0.75
328 Feline infectious peritonitis virus. II. Propagation in suckling mouse brain. Zentralbl Veterinarmed B 1978 0.75
329 Need to increase awareness among family doctors and medical specialists of rickettsioses as an import disease in non-endemic areas. Neth J Med 2000 0.75
330 [Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza]. Ned Tijdschr Geneeskd 2004 0.75
331 Round table on morbilliviruses in marine mammals. Vet Microbiol 1992 0.75
332 [Parvovirus-vaccination in dogs]. Tijdschr Diergeneeskd 1991 0.75
333 Purification of infectious canine parvovirus from cell culture by affinity chromatography with monoclonal antibodies. J Virol Methods 1987 0.75
334 Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes. J Med Virol 2001 0.75
335 [The harbor seal (Phoca vitulina) in the last century]. Tijdschr Diergeneeskd 2000 0.75
336 Induction of feline immunodeficiency virus specific antibodies in cats with an attenuated Salmonella strain expressing the Gag protein. Vaccine 1997 0.75
337 [Developments in biotechnology; implications for diagnosis in pet animals]. Tijdschr Diergeneeskd 1987 0.75
338 [Universal influenza vaccine still far in the future]. Ned Tijdschr Geneeskd 1999 0.75
339 Virus replication and evolution drive the kinetics and specificity of SIV-specific cytotoxic T lymphocytes. Immunol Rev 2001 0.75
340 Patient to patient hepatitis B transmission during heart biopsy procedures. A report of the European Working Party on Viral Hepatitis in Heart Transplant Recipients. J Hosp Infect 1996 0.75
341 Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system. Dev Biol Stand 1984 0.75
342 [Current developments in hybridoma technology]. Tijdschr Diergeneeskd 1985 0.75
343 [Influenza in the 1994/95 season; composition of vaccine for the 1995/96 season]. Ned Tijdschr Geneeskd 1995 0.75
344 Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins. Vaccine 1997 0.75
345 Preservation of phenotype and function of positively selected virus-specific CD8+ T lymphocytes following anti-Fab detachment from immunomagnetic beads. J Immunol Methods 1993 0.75
346 A candidate phocid herpesvirus vaccine that provides protection against feline herpesvirus infection. Vaccine 2001 0.75
347 [Another case of Hantaan virus infection in The Netherlands]. Ned Tijdschr Geneeskd 1989 0.75
348 [Hantaan virus infection, a seldom recognized cause of acute kidney insufficiency]. Ned Tijdschr Geneeskd 1991 0.75
349 [Influenza in the 1996/'97 season; vaccine composition for the 1997/'98 season]. Ned Tijdschr Geneeskd 1997 0.75
350 Interferon-alpha therapy for chronic hepatitis B: early response related to pre-treatment changes in viral replication. J Med Virol 2001 0.75
351 Virologic control of monkeys used for the production of poliomyelitis virus vaccine. Dev Biol Stand 1981 0.75
352 [Canine parvovirus infection in dogs: a consideration]. Tijdschr Diergeneeskd 1986 0.75
353 Simian immunodeficiency virus (SIV)-specific CD8+ cytotoxic T lymphocyte responses of naive and vaccinated cynomolgus macaques infected with SIVmac32H(J5): quantitative analysis by in vitro antigenic stimulation. Vaccine 1997 0.75
354 Detection of tomato spotted wilt virus using monoclonal antibodies and riboprobes. Arch Virol 1990 0.75
355 [Bovine spongiform encephalopathy (BSE), a review]. Tijdschr Diergeneeskd 1990 0.75
356 Age-related disease in recurrent outbreak of phocid herpesvirus type-1 infections in a seal rehabilitation centre: evaluation of diagnostic methods. Vet Rec 1997 0.75
357 Monoclonal antibodies against the K99 antigen of Escherichia coli for diagnostic purposes. Zentralbl Bakteriol Mikrobiol Hyg A 1986 0.75
358 Influenza season 2000/01 vaccine dose-response studies. Vaccine 2000 0.75
359 [Studies on the etiology of feline infectious peritonitis. Preliminary communication]. Berl Munch Tierarztl Wochenschr 1976 0.75
360 [Feline leukemia virus (FeLV) and FeLV-associated diseases in cats: a review]. Tijdschr Diergeneeskd 1987 0.75
361 Immune functions in beluga whales (Delphinapterus leucas): evaluation of natural killer cell activity. Vet Immunol Immunopathol 1997 0.75
362 Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents. Vaccine 1996 0.75
363 Prevalence of antibodies to equine viruses in the Netherlands. Vet Q 1979 0.75
364 Seal death. Nature 1988 0.75
365 Strain differentiation of polioviruses with monoclonal antibodies. Dev Biol Stand 1984 0.75
366 Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance. Vet Q 1996 0.75
367 [Some viral zoonoses transmitted by pets (author's transl)]. Tijdschr Diergeneeskd 1977 0.75
368 A novel generation of viral vaccines based on the ISCOM matrix. Pharm Biotechnol 1995 0.75
369 Application of monoclonal antibodies in the Dutch avian leukosis control programme. Avian Pathol 1985 0.75
370 Monoclonal antibodies to P2 basic protein and their use in the investigation of some aspects of the Guillain-Barré syndrome. J Neurol Sci 1988 0.75
371 Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines. Vaccine 2000 0.75
372 Prevalence of morbilliviruses among pinniped and cetacean species. Rev Sci Tech 1993 0.75
373 Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing. J Virol Methods 1996 0.75
374 Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice. Antiviral Res 1997 0.75
375 Heat inactivation of serum may interfere with HTLV-III/LAV serology. Lancet 1985 0.75
376 Feline infectious peritonitis virus. Zentralbl Veterinarmed B 1977 0.75